REGN registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Completion date | Jul 5, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Jul 5, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Completion date | May 29, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 16, 2026, 12:25 PM ET | Status | Unknown status | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Completion date | Jan 2028 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Primary completion date | Jul 2027 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Completion date | Oct 21, 2026 (actual) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Status | Completed | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Completion date | Nov 30, 2029 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Primary completion date | Feb 29, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Status | Recruiting | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETResults posted
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETCompletion dateNCT06169527A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving DupilumabSNYREGN
- Now
- Jul 5, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion dateNCT06169527A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving DupilumabSNYREGN
- Now
- Jul 5, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETCompletion dateNCT06230224A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated...REGN
- Now
- May 29, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT07863024Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets...REGN
- Now
- Recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETResults postedNCT05394116A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants...REGN
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 16, 2026, 12:25 PM ETStatusNCT06665971Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)REGN
- Now
- Unknown status
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETCompletion date
- Now
- Jan 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETPrimary completion date
- Now
- Jul 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETCompletion dateNCT06299098A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult...REGN
- Now
- Oct 21, 2026 (actual)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETStatusNCT06299098A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult...REGN
- Now
- Completed
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETCompletion dateNCT06091254A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of...REGN
- Now
- Nov 30, 2029 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETPrimary completion dateNCT06091254A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of...REGN
- Now
- Feb 29, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETStatusNCT05519475A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated...REGN
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETStatusNCT06444880Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient MalignanciesREGN
- Now
- Recruiting
- Before
- Locked
The previous value and the sponsor's record update date are locked on 15 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.